Skip to main content
OpenTrials

Clinical trial condition

Very Long Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency

Explore clinical trials studying Very Long Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Very Long Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency trial results

Completed

Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) Extension Study for Subjects Previously Enrolled in Triheptanoin Studies

NCT02214160

Conditions
Carnitine Palmitoyltransferase (CPT I or CPT II) Deficiency, Carnitine-acylcarnitine Translocase (CACT) Deficiency, Long-chain 3-hydroxy-acyl-CoA Dehydrogenase (LCHAD) Deficiency, +3 more
Locations
  • University of California San Francisco San Francisco, California, United States
  • Children's National Health System Washington D.C., District of Columbia, United States
  • University of South Florida Tampa, Florida, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
View Trial Details
Completed

A Study of UX007 (Triheptanoin) in Participants With Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD)

NCT01886378

Conditions
Carnitine Palmitoyltransferase (CPT II) Deficiency, Long-chain Fatty Acid Oxidation Disorders (LC-FAOD), Longchain 3-hydroxy-acyl-CoA Dehydrogenase (LCHAD) Deficiency, +3 more
Locations
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • University of Southern Florida Tampa, Florida, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • Boston Children's Hospital Boston, Massachusetts, United States
View Trial Details

Related conditions